Interline Therapeutics’ $92 million Series Seed and Series A financing

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Interline Therapeutics on the deal.Interline Therapeutics, a data science and healthcare company, announced its $92 million Series Seed…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here